M&A Deal Summary |
|
---|---|
Date | 2018-04-24 |
Target | OREXIGEN Therapeutics |
Sector | Life Science |
Buyer(s) | Nalpropion Pharmaceuticals |
Deal Type | Special Situations/Distressed |
Deal Value | 75M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2018 |
Sector | Life Science |
Nalpropion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of weight loss. Nalpropion Pharmaceuticals was formed in 2018 and is based in San Diego, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Special Situations/Distressed) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2018) | 1 of 1 |
Size (of disclosed) | 1 of 1 |